| Device |
implanted electrical device intended for treatment of fecal incontinence |
| Regulation Description |
Implanted electrical urinary continence device. |
| Definition |
Treatment of chronic fecal incontinence |
| Physical State |
Receiver implanted in the abdomen with electrodes for pulsed-stimulation that are implanted either in the bladder wall or in the pelvic floor, and a battery-powered transmitter outside the body |
| Technical Method |
Electrical stimulation of the sacral nerve |
| Target Area |
Sacral nerve, bladder, urinary and anal sphincters, pelvic floor, and rectosigmoid colon |
| Regulation Medical Specialty |
Gastroenterology/Urology |
| Review Panel |
Gastroenterology/Urology |
| Product Code | QON |
| Premarket Review |
Renal, Gastrointestinal, Obesity and Transplant Devices
(DHT3A)
Renal, Gastrointestinal, Obesity and Transplant Devices
(DHT3A)
|
| Submission Type |
PMA
|
| Regulation Number |
876.5270
|
| Device Class |
3
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
Yes
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |